Glucagon-like peptide-1 receptor agonists to treat chronic kidney disease associated with type 2 diabetes

被引：0
作者：
Khan, Irfan [1 ]
Lanktree, Matthew B. [2 ]
机构：
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] McMaster Univ, Dept Med Ainsi Que Methodes Donnees & Incidences R, Hamilton, ON, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2025年 / 197卷 / 06期
关键词：
D O I：
10.1503/cmaj.240469-f
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E165 / E166
页数：2
相关论文
共 50 条
[41]   Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes [J].
Dankner, Rachel ;
Murad, Havi ;
Agay, Nirit ;
Olmer, Liraz ;
Freedman, Laurence S. .
JAMA NETWORK OPEN, 2024, 7 (01) :E2350408
[42]   Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 Diabetes [J].
Popovic, Djordje S. ;
Papachristou, Stella ;
Papanas, Nikolaos .
CURRENT VASCULAR PHARMACOLOGY, 2025,
[43]   Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists [J].
Foer, Dinah ;
Beeler, Patrick E. ;
Cui, Jing ;
Karlson, Elizabeth W. ;
Bates, David W. ;
Cahill, Katherine N. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (07) :831-840
[44]   Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features [J].
Katherine A. Lyseng-Williamson .
Clinical Drug Investigation, 2019, 39 :1019-1019
[45]   Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes [J].
Kuo, Chia-Chih ;
Chuang, Min-Hsiang ;
Li, Chun-Hsien ;
Tsai, Ya-Wen ;
Huang, Po-Yu ;
Kuo, Hsing-Tao ;
Lai, Chih-Cheng .
DIABETOLOGIA, 2025,
[46]   Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features [J].
Katherine A. Lyseng-Williamson .
Clinical Drug Investigation, 2020, 40 :291-291
[47]   Obesity and Glucagon-Like Peptide-1 Receptor Agonists [J].
Celletti, Francesca ;
Branca, Francesco ;
Farrar, Jeremy .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (07) :561-562
[48]   Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus [J].
Harris, Kira B. ;
McCarty, Delilah J. .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) :3-18
[49]   Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future [J].
Filipe Ferrari ;
Rafael S. Scheffel ;
Vítor M. Martins ;
Raul D. Santos ;
Ricardo Stein .
American Journal of Cardiovascular Drugs, 2022, 22 :363-383
[50]   Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists [J].
Khan, Sadiya S. ;
Ndumele, Chiadi E. ;
Kazi, Dhruv S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02) :113-114
12345